Skip to main content

Winters Chad's Form 4/A amendment

Amended

West Pharmaceutical Services Inc (WST) · filed Dec 21, 2023

Accession no.
0001127602-23-030255
Filed
Dec 21, 2023
Trade date
Dec 4, 2023
Filing delay
17 days
Rule 10b5-1 plan
Not checked
Original filed
Dec 5, 2023

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $353.5K. It was filed 17 days after the trade.

This amendment replaces 0001127602-23-028965 (filed Dec 5, 2023).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Winters ChadCIK 0001811424Officer (VP, Chief Accounting Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 4, 2023Common StockMOption exerciseAcquired+456$143.43+$65,404.081,941.7Direct
Dec 4, 2023Common StockSSaleDisposed−1,013$349.00−$353,5371,269.7Direct
Dec 4, 2023Common StockMOption exerciseAcquired+341$173.22+$59,068.022,282.7Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 4, 2023Stock Options (Right to Buy)MOption exerciseDisposed−456$0.00$00Direct
Dec 4, 2023Stock Options (Right to Buy)MOption exerciseDisposed−341$0.00$01,571Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)